文献速递艾滋病与性传播感染

MACS/WIHS队列中HIV女性整合酶抑制剂相关体重增加的纵向血清代谢组学特征

Longitudinal Serum Metabolomic Signatures Related to Integrase Strand Transfer Inhibitors-Associated Weight Gain in Women with HIV Enrolled in the MACS/WIHS Combined Cohort Study.
PubMed 文献 · J Infect Dis · 2026-06-29

本研究纳入192名MACS/WIHS队列参与者,包括38名启动INSTI的病毒学抑制HIV女性、88名维持原方案的HIV女性和66名无HIV女性,采用纵向非靶向代谢组学分析。结果显示INSTI组中体重增加者与维持者的差异代谢物富集于16条通路,以脂质相关通路为主(56%),包括亚油酸和花生四烯酸代谢。

要点

  • INSTI相关体重增加的HIV女性呈现以脂质和多不饱和脂肪酸为主的代谢特征。
  • INSTI组差异代谢物富集通路中脂质相关占56%,主要为亚油酸和花生四烯酸代谢。
  • 非INSTI组和无HIV女性差异代谢物涉及更广泛通路,包括氨基酸代谢。

核心结论

  • INSTI治疗的HIV女性体重增加具有独特的脂质和多不饱和脂肪酸主导的代谢谱。

研究设计与样本

  • 纵向非靶向代谢组学研究,分析MACS/WIHS队列192名参与者血清,其中INSTI组38人、非INSTI组88人、无HIV女性66人。

主要发现

  • INSTI组中体重增加者与维持者的差异代谢物在多个时间点富集于16条通路,脂质相关占56%,包括亚油酸和花生四烯酸代谢。
  • 非INSTI组和无HIV女性组的差异代谢物涉及更广泛通路,包括氨基酸代谢。

关键数值与推荐

  • 平均年龄45.7±8.9岁,平均BMI 32.4±8.3 kg/m2,组间无差异。
  • 各组内体重增加者与维持者人口学特征可比(p > 0.05)。

临床怎么用

  • 提示INSTI相关体重增加可能通过脂质和多不饱和脂肪酸代谢途径介导,为干预策略提供机制线索。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Integrase strand-transfer inhibitors (INSTIs) are associated with weight gain in people with HIV (PWH), particularly in women with HIV (WWH), but underlying mechanisms remain unclear. We used longitudinal untargeted metabolomics to identify metabolic signatures of INSTI-related weight gain in WWH. METHODS: We analyzed serum from 192 participants in the Women's Interagency HIV Study: 38 virologically suppressed WWH who initiated INSTIs (INSTI group), 88 virologically suppressed WWH who remained on their original antiretroviral therapy (non-INSTI group), and 66 women without HIV (WWoH). Samples were collected at baseline (6-12 months before INSTI initiation), 1-6 months post-initiation, and 1-2 years post-initiation, with matched visits for controls. High-resolution metabolomics was performed by liquid chromatography-mass spectrometry. Within each group, linear mixed-effects models adjusted for baseline age and BMI compared longitudinal metabolite changes between weight gainers and maintainers, and significant features were analyzed by Mummichog v2.0 pathway enrichment. RESULTS: Mean age was 45.7 ± 8.9 years and mean BMI 32.4 ± 8.3 kg/m2, with no differences across groups; within each group, gainers and maintainers were demographically comparable (p > 0.05). In the INSTI group, metabolites differentiating gainers from maintainers were enriched in 16 pathways across timepoints, predominantly lipid-related (56%), including the polyunsaturated fatty acid (PUFA) pathways linoleic acid and arachidonic acid metabolism. In the non-INSTI and WWoH groups, differentiating metabolites spanned a broader range of pathways, including amino acid metabolism. CONCLUSIONS: Weight gain among INSTI-treated WWH is characterized by a distinct, lipid- and PUFA-dominated metabolic profile, providing mechanistic insight that may inform therapeutic strategies.

来源:J Infect Dis,查看原文。版权归原作者所有。

引用

  1. Yang CA, Go YM, Jones DP, et al. Longitudinal Serum Metabolomic Signatures Related to Integrase Strand Transfer Inhibitors-Associated Weight Gain in Women with HIV Enrolled in the MACS/WIHS Combined Cohort Study. J Infect Dis. 2026. PMID: 42366600. doi:10.1093/infdis/jiag316

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。